课题基金 / 基金详情

Evaluating the impact of a mandatory switching policy for biosimilars

Evaluating the impact of a mandatory switching policy for biosimilars
评估生物仿制药强制转换政策的影响
批准号:
433433
负责人:
Harrison Mark
金额:
$21.73万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-10-01 至 2023-10-01

项目摘要

项目成果

Harrison Mark的其他基金

相似基金

相关文献

中文摘要
翻译
生物药物已经彻底改变了许多慢性疾病患者的护理,包括炎症性疾病(包括风湿性和肠道疾病)。生物药物是非常昂贵的,和三个最昂贵的药物对加拿大的健康
英文摘要
Biologic drugs have revolutionized the care of patients with many chronic diseases including inflammatory diseases (including rheumatic and bowel diseases). Biologic drugs are extremely expensive, and three of the most costly drugs to the Canadian health
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploring health vulnerabilities to climate change: a participatory approach to research design
  • 批准号:
    460977
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $1.45万
  • 财政年份:
    2022
  • 负责人:
    Harrison Mark
  • 依托单位:
A population-based analysis of multi-disciplinary rheumatology nursing care for people with complex rheumatic diseases.
  • 批准号:
    344549
  • 项目类别:
    Operating Grants
  • 资助金额:
    $19.77万
  • 财政年份:
    2016
  • 负责人:
    Harrison Mark
  • 依托单位:
海外基金